Kanie, T., Mizuno, A., Yoneoka, D., Tam, W. W. S., Morze, J., Rynkiewicz, A., Xin, Y., Wu, O. and Kwong, J. S. (2020) Dipeptidyl peptidase-4 inhibitors, glucagon-like peptide 1 receptor agonists and sodium-glucose co-transporter-2 inhibitors for people with cardiovascular disease: a network meta-analysis (Protocol). Cochrane Database of Systematic Reviews, 2020(6), CD013650. (doi: 10.1002/14651858.cd013650) (PMCID:PMC7387055)
Text
219620.pdf - Published Version 238kB |
Abstract
Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows: To systematically review the available evidence on the effects (benefits and harms) of DPP‐4 inhibitors, GLP‐1 receptor agonists, and SGLT‐2 inhibitors in people with established CVD, using network meta‐analysis.
Item Type: | Articles |
---|---|
Status: | Published |
Refereed: | Yes |
Glasgow Author(s) Enlighten ID: | Wu, Professor Olivia |
Authors: | Kanie, T., Mizuno, A., Yoneoka, D., Tam, W. W. S., Morze, J., Rynkiewicz, A., Xin, Y., Wu, O., and Kwong, J. S. |
College/School: | College of Medical Veterinary and Life Sciences > School of Health & Wellbeing > Health Economics and Health Technology Assessment |
Journal Name: | Cochrane Database of Systematic Reviews |
Publisher: | Wiley |
ISSN: | 1469-493X |
Published Online: | 24 June 2020 |
Copyright Holders: | Copyright © 2020 The Cochrane Collaboration |
First Published: | First published in Cochrane Database of Systematic Reviews 2020(6): CD013650 |
Publisher Policy: | Reproduced in accordance with the publisher copyright policy |
University Staff: Request a correction | Enlighten Editors: Update this record